ExADO is copious in microdialysates from tumoral core regions (178) and tumor hypoxia promotes ADO formation by hypoxia-inducible factor 1α/β (HIF-1α/β)-induced CD39 and CD73 expression (179–182). Here, ENTPD1 is linked to neoplasm.